Inafielddominatedbyexternalbeamradiationtherapy(EBRT),boththetherapeuticandtechnicalpossibilities ofbrachytherapy(BT)areunderrated,shadowedbyprotonsandintensitymodulatedradiotherapy.Decreasingexpertiseandindications,aswellasincreasinglackofspecificBTtrainingforradiationtherapy(RT)residentsledtothereal needofshorteningitslearningcurveandmakingitmorepopular.DevelopingroboticBTdevicescanbeawaytomiti gatetheaboveissues.TherearemanyteamsworkingatcustommaderoboticBTplatformstoperfectandovercome thelimitationsoftheexistingsystems.Thispaperprovidesapictureofthecurrentstateoftheartinroboticassisted BT,asitalsoconveystheauthor'ssolutiontotheproblem,aparallelrobotthatusesCTguidance.
Purpose
For some, brachytherapy (BT) is something on the brink of extinction and their arguments are not scarce. Brachytherapy might not sound too appealing for the average radiation oncologist because it implies transitionfrombehindthescreentotheOR.Bloodappearsas arealscenarioandmostofthemchosefromthebeginningtoavoiditwillingly.Itisnotonlyaboutthelackof surgicalskills,butalsothatmostjuniorradiationoncologistsdonotactuallyhavethechancetoseeorpractice the technique in their centers. Moreover, BT is by itself a niche domain, as there are rather few indications for it, as compared to external beam radiotherapy (EBRT). Therefore, for most of them, BT is something more like "seenottouch".Lastbutnotleast,inadomaindrivenby EBRT,investinginBTmightnotseemtooappealingfor developers.
Fortunately, some of these issues can be corrected. With proper indications and good technique, BT can achieveexcellentresults.Thus,intheirefforttokeepthe domainalive,doctorsthatadvocateforittriedtoreplace thehumanhandforthe"bloody"partwhilekeepingthe radiationtherapyspiritfriendlytoradiationoncologists. Asaresultofthisstruggleforaccessibility,safety,precision,andaccuracy,BTroboticsystemsappeared.
Theaimofthispaperistoevaluatethecurrentsituationinthefieldofroboticbrachytherapy,brieflyoutline the existing systems, their technical aspects, and limitations, and to present a custommade solution to the problem,auniversalbrachytherapyroboticsystem,Para BrachyRob.
Technical considerations
ThepurposeofBTistoachieve,byinterstitialradioactiveseedimplantation(lowdoserate-LDRbrachytherapy) or temporary source implantation (highdoserate -HDR,orpulsedoserate-PDRbrachytherapy),ahigh conformaldosedistributiontocoverthetargetvolume. Atthesametime,BTallowsasteepdecreaseofthedose outsideofthedesiredvolume.Itisthusanefficienttreatmentforvirtualanysmalltomediumsizedwelldefined tumor, which can be reached by visual/palpable guidance, provided that correct indications and accurate technique are met. While the indication is based only on knowledge, usually set by multidisciplinary team (MDT) decision, the technique requires a high degree of skill and the use of realtime image guidance, which canbeimprovedbyautomation.Thereportofthejoint Task Group 192 of the American Association of PhysicistsinMedicine(AAPM)andtheGroupeEuropéende Curiethérapie(GEC)EuropeanSocietyforRadiotherapy & Oncology (ESTRO) reviews the Robotics Institute of America's (RIA) definition and classification of robots, andmakesacleardistinctionbetween"automation"and "autonomy" [1] .Itraisestwofundamentalquestionson "autonomy by an automatic system": autonomy from whom? and autonomy to do what? The first addresses thematterofpermissionfortherobottoconductitsoperationswithouthumansupervision.Thesecondbuilds on the "degrees of automation" described by Sheridan (plan, teach, monitor, intervene, learn) [2] and refers to treatmentexecution,supervisionoftreatmentplanning, monitoring,andintervention.Italsoproposesthemodi-ficationofsystemperformancebasedonpreviouslearningorteachingexperiences.
Based on these degrees, the report proposes a new classificationofautomaticsystems,moreappropriatefor BTrobotsanddifferentfromthatelaboratedbytheRIA. Instead of subdividing robots into Classes (14), it puts themonfourLevelsofAutonomy(IIV).Thedenomination "Class (14) robot operating at Level of Autonomy (IIV)"mightnotbeuncommon.Therearecurrentlyno availableLevelIVmedicalrobots,i.e.machinescapable to create and complete all the tasks without human interaction [1] . Astheyyetdonotpossessfullautonomyandworkin ahumanenvironment,BTroboticsystemsarerequiredto meet the SAUR (safety, accuracy, userfriendliness, and reliability) criteria. Indeed, apart from widening the indications of the technique, increasing its availability by automation and by reducing the learning curve, these robotsaimatimprovingaccuracy.WhenappliedforpermanentBT,thisrelatestopreciseseedplacement,finding optimal seed locations, decreasing surgical trauma, and finallyprotectingmedicalstafffromradiationexposure. Anextensivelistoftheadditionalfunctionalrecommendations on robotic BT systems can be consulted in the jointTaskGroup192'sReport [1] .
However,theultimatepurposeisnottobringamachinetotheexistinglevelofhumanexpertisebuttobetter implantsandenhancethequalityofcareinaconsistent, reproducibleway.Thismeansextendingtheindications of BT while keeping it at the same level of minimal invasivenessorevenincreasingtheefficacy/toxicityratio. A checklist that should be satisfied by every BT robotic systeminthisrespectisprovidedbythesamereport.In terms of accuracy, manual seeds placement have an accuracyof36mmwhenplacedinvivowitharigidtem-plate.Conversely,roboticsystemsarerequiredtoacquire aspatialaccuracyoflessthan1mminphantommodels. They are also demanded to solve issues such as tissue deformation (by rotational needle insertion), needle deviation(fixedneedletrajectory,sensorsforpressureand pulsations), and to avoid edema, which would prevent thecorrectdistributionofthedelivereddoseasplanned preimplantandintraoperatively(dynamicplanningby update of dosimetry). Patient position and existing imaging technology can be limiting the robotic system's degree of freedom (DOF), and construction materials (forexample,the dorsallithotomic position forprostate brachytherapy might impair the transperineal insertion with direct visualization on CT and/or MRI because of thelimitedspaceintheCT/MRI/Bore;allthecablesfor MRIguidedrobotmustbewithnomagnetizablematerial suchironorcopper,risingsignificantlythecosts).System adaptabilityisadvisedsothatthefutureadvancesin3D imagingtechnologycouldofferarealadvantagetothese systems. Prostate deformation/rotation during implant andbeveltipneedlesteeringeffectleadalsotoproblems suchassignificanttargetdisplacementsandspinning,respectively. At the same time, reaching a higher level of autonomyishinderedbytheoperator'sneedofmanual controlandtheconsequentpreferenceforamasterslave interface. From this perspective, the catheter placement in the abdomen, pelvis, or thorax can be guided by the da Vinci surgery robot, after resection, biopsy, or if the cancerisjudgedinoperable.
Existing systems
Imageguided brachytherapy (IGBT) comprises BT robotic systems that currently use MRI (magnetic resonance imaging), CT (computed tomography), or TRUS (transrectal ultrasound). While the first provides the best soft tissue contrast, the last is the most commonly used due to cost and availability advantages. There are a dozen of robotic systems developed worldwide, few to have been used on patients (FIRST [3] , EUCLIDEAN [4] , and JHU1 [5] ). Only one has received the FDA and CE approvals and become commercially available for prostateBTapplications:FullyIntegratedRealtimeSeed Treatment (FIRST TM system, Oncentra Integrated ProstateSolutiondevice,ElektaNucletron,Veenendaal,The Netherlands,aLevelIIroboticsystem) [6] .
The AAPM and GECESTRO guideline for imageguidedroboticBTReportofTaskGroup192issued inOctober2014 [1] [1] . ThemeancalibrationerrorfortheprostateBTrobotsisin therangeof0.5mm.Intissuemimickingphantoms,the meanneedleangulations'errorat10cmdepthisaround 0.5º,translatingintoaseedplacementoverallmeanerror ofaround3mm.Inpractice,themaincontributorforerroristheneedledeflectionthroughtherealprostate(due to different tissue densities including cancer stiffness, adenomaelasticity,prostatecalcifications,orpreviously insertedseeds,etc.).
The majority of systems have thus been tailored for prostateandlungsourceimplantation(thelattertoalesserextent).Therefore,implementingauniversalBTroboticsystemisoneofthefield'smaindirectionsofdevelopment [7, 8] .
Our experience: the Para-BrachyRob (PBR)
A solution to the above mentioned limitations was proposed by The Research Center for Industrial Robots SimulationandTesting(CESTER)ClujNapoca,Romania [9] ,whichdevelopedafamilyofmodularparallelrobots for brachytherapy (BR1, BR2, BR3) (Figure 2) for HDR brachytherapy.TheaimwastoobtainCTbaseddosimetry for inoperable cancers with robotic assisted needle placement(thoracic,abdominal,andpelviccancers) (Figure3) .Basedonsimulationresultsandontheexpertise of radiation oncology specialists, the last system, BR3, wasselectedforfurtherdevelopmentintoanexperimentalmodel.TheconstructivesolutionisaCTcompatible, remote control, and portable system with 5 degrees of freedom (DOF): X, Y, Z, angulation and rotation. It is smallenoughtofitthe80cmgantrywhenmountedon the CTtable but it can be also fixed to the ground. The systemhasabackupbattery.
ThekinematicschemeofPBRconsistsoftwocylindricalmodulesof3DOFeach.Besidesthesimilarfirsttwo active joints, which perform a translational movement, one of the modules associates a third rotational joint. They both associate two distal passive joints, while an additionalactivejointischaracteristicoftheneedleinsertionmodule.Thankstothisstructure,theBR3modelof PBReliminatesthefixedframeoftheprevioustwomodels,BR1andBR2 [10] .
Inbrief,thesystem'stechnicalrequirementsinclude: (1)5DOF(X,Y,Z,Ψ,θ),(2)doublerigidgripforneedles ofvariouslengths(525cm),(3)sterilecapforneedlecontact,(4)sensorforresistanceandforvibration,withdual signalization (audio and visual), (5) precision of in vivo contact<3mminanydirection,(6)automaticchargerfor upto20needles,and (7)doublesafetyblockingmechanism.Wearecurrentlyinthepreclinicalphase.ThevirtualpatientisplacedinthetreatmentpositionontheCT couch.Acontiguous2mmslicethicknessCTacquisition ofthezoneofinterestisdone.Asprinciple,thecoordinatesofthetargetarelinkedwiththeexternaltattoos(as inEBRT),theattachingpointsoftherobottothecouch, andwiththefiducialsplacedinthetumororinits'close proximity.Thecontouringofthetargetandorgansatrisk isdonelikeforaclassicalEBRTplanning.Thesoftware proposes solutions for needle placement, avoiding the organs at risk (preplan). Optimization is performed by differentanglesinsertionsifneeded,untilallthedosimetrypredefinedconstraintsarefulfilled.Finalapprovalby thephysicianandphysicistinchargeendstheplanning procedure.Thenextday,thepatient,underlocal,spinal orgeneralanesthesia(asrequiredbythetumorlocalization)isrepositionedthesamewayontheCTcouch(laser alignment on thetattoos,as for EBRT),andthe robot is rigidly attached to the couch in the specially designed articulation points (visible on the CT images). Then the robotautomaticallymovestotheinsertionstartposition, accordingtotheshiftsgeneratedbytheplanningsystem andstartstheimplantation,withthemost"safe"needle, under CT guidance in any particular moment asked by theoperatingteam.TheprocedureischeckedperiodicallyfromoutsidetheroombycouplesofCTslices(oralternativelyfrominsidetheoperatingroombytransabdominalultrasound)andpursuitcatheterbycatheter,ifonly minordeviationsareencountered.FinalCTacquisitionis donefortherealdosimetry,andHDR(orPDR)BTplan 
Conclusions
Atpresent,automate(partialorfullprocedure)seems tobethebestsolutionforbringingBTbacktostage.By increasingitsavailabilityandconsequentlyreducingthe technique'slearningcurve,morejuniorradiationoncologistsareexpectedtoturntheirattentiontoBT,and,consequently, more patients could benefit. For the timebeing, the Oncentra Integrated Prostate Solution device is theonlyroboticsystemcommerciallyavailableforLDR seeds BT. Among a dozen of custommade and under developmentsystems,ourparallelrobotParaBrachyrob, thankstoitsversatilityandtechnicalcapabilities,might beapioneerofthenextgenerationprecisiontoolsinBT.
